Directed Evolution to Low Nanomolar Affinity of a Tumor-Targeting Epidermal Growth Factor Receptor-Binding Affibody Molecule
- 7 March 2008
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 376 (5) , 1388-1402
- https://doi.org/10.1016/j.jmb.2007.12.060
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A Designed Ankyrin Repeat Protein Evolved to Picomolar Affinity to Her2Journal of Molecular Biology, 2007
- Evolution of an Interloop Disulfide Bond in High-Affinity Antibody Mimics Based on Fibronectin Type III Domain and Selected by Yeast Surface Display: Molecular Convergence with Single-Domain Camelid and Shark AntibodiesJournal of Molecular Biology, 2007
- A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptorsProceedings of the National Academy of Sciences, 2007
- Directed Evolution of an Anti-prion Protein scFv Fragment to an Affinity of 1 pM and its Structural InterpretationJournal of Molecular Biology, 2006
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- EGFR and cancer prognosisPublished by Elsevier ,2001
- Phenotype vs Genotype in the Evolution of Astrocytic Brain TumorsToxicologic Pathology, 2000
- Primary and secondary glioblastomas: From concept to clinical diagnosisNeuro-Oncology, 1999
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996